Canine epilepsy affects approximately 0.6-0.75% of dogs and requires long-term management strategies that prioritize quality of life alongside seizure control.
Managing epilepsy in dogs involves balancing seizure frequency reduction against drug side effects, which can include sedation, weight gain, and liver toxicity with long-term phenobarbital use. Quality-of-life assessments should include both seizure burden and drug-related impacts. Owner education about seizure first aid, rescue medications, and trigger identification is essential. Regular monitoring of liver enzymes and drug levels prevents toxicity. Dogs with controlled epilepsy can lead fulfilling lives with appropriate management.